Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.

Tan B, Wong JJ, Sultana R, Koh JCJW, Jit M, Mok YH, Lee JH.

JAMA Pediatr. 2019 Feb 11. doi: 10.1001/jamapediatrics.2018.4839. [Epub ahead of print]

PMID:
30742207
2.

Within-host dynamics shape antibiotic resistance in commensal bacteria.

Davies NG, Flasche S, Jit M, Atkins KE.

Nat Ecol Evol. 2019 Feb 11. doi: 10.1038/s41559-018-0786-x. [Epub ahead of print]

PMID:
30742105
3.

The role of pneumococcal conjugate vaccination in reducing pneumonia mortality.

Jit M, Flasche S.

Lancet Glob Health. 2019 Feb;7(2):e173-e174. doi: 10.1016/S2214-109X(18)30540-0. No abstract available.

4.

Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.

Ong KJ, Checchi M, Burns L, Pavitt C, Postma MJ, Jit M.

Sex Transm Infect. 2019 Feb;95(1):28-35. doi: 10.1136/sextrans-2018-053606. Epub 2018 Sep 21.

PMID:
30674687
5.

Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR.

Sevilla JP, Bloom DE, Cadarette D, Jit M, Lipsitch M.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12911-12919. doi: 10.1073/pnas.1717161115.

6.

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis.

Chen C, Cervero Liceras F, Flasche S, Sidharta S, Yoong J, Sundaram N, Jit M.

Lancet Glob Health. 2019 Jan;7(1):e58-e67. doi: 10.1016/S2214-109X(18)30422-4.

7.
8.

MCDA from a health economics perspective: opportunities and pitfalls of extending economic evaluation to incorporate broader outcomes.

Jit M.

Cost Eff Resour Alloc. 2018 Nov 9;16(Suppl 1):45. doi: 10.1186/s12962-018-0118-7. eCollection 2018.

9.
10.

Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature.

Drolet M, Bénard É, Jit M, Hutubessy R, Brisson M.

Value Health. 2018 Oct;21(10):1250-1258. doi: 10.1016/j.jval.2018.03.014. Epub 2018 May 24. Review.

11.

Economic Analysis of Vaccination Programs.

Mauskopf J, Standaert B, Connolly MP, Culyer AJ, Garrison LP, Hutubessy R, Jit M, Pitman R, Revill P, Severens JL.

Value Health. 2018 Oct;21(10):1133-1149. doi: 10.1016/j.jval.2018.08.005. Review.

PMID:
30314613
12.

Determining environmental and anthropogenic factors which explain the global distribution of Aedes aegypti and Ae. albopictus.

Dickens BL, Sun H, Jit M, Cook AR, Carrasco LR.

BMJ Glob Health. 2018 Sep 3;3(4):e000801. doi: 10.1136/bmjgh-2018-000801. eCollection 2018.

13.
14.

Determinants of methicillin-resistant Staphylococcus aureus (MRSA) prevalence in the Asia-Pacific region: A systematic review and meta-analysis.

Lim WW, Wu P, Bond HS, Wong JY, Ni K, Seto WH, Jit M, Cowling BJ.

J Glob Antimicrob Resist. 2018 Aug 23;16:17-27. doi: 10.1016/j.jgar.2018.08.014. [Epub ahead of print] Review.

16.

Revisiting the winter burden of acute gastroenteritis on hospital beds in England: change in data collection supports analytical method for previously missing values.

Sandmann FG, Jit M, Robotham JV, Deeny SR.

J Hosp Infect. 2018 Sep;100(1):115-117. doi: 10.1016/j.jhin.2018.06.008. Epub 2018 Jun 13. No abstract available.

PMID:
29908252
17.

Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs.

Markowitz LE, Drolet M, Perez N, Jit M, Brisson M.

Vaccine. 2018 Aug 6;36(32 Pt A):4806-4815. doi: 10.1016/j.vaccine.2018.01.057. Epub 2018 May 22. Review.

18.

PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.

Bate J, Baker S, Breuer J, Chisholm JC, Gray J, Hambleton S, Houlton A, Jit M, Lowis S, Makin G, O'Sullivan C, Patel SR, Phillips R, Ransinghe N, Ramsay ME, Skinner R, Wheatley K, Heath PT.

Arch Dis Child. 2019 Jan;104(1):25-29. doi: 10.1136/archdischild-2017-314212. Epub 2018 May 5.

PMID:
29730641
19.

A bibliometric analysis of systematic reviews on vaccines and immunisation.

Fernandes S, Jit M, Bozzani F, Griffiths UK, Scott JAG, Burchett HED.

Vaccine. 2018 Apr 19;36(17):2254-2261. doi: 10.1016/j.vaccine.2018.02.049. Epub 2018 Mar 22. Review.

20.

Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients.

Sandmann FG, Shallcross L, Adams N, Allen DJ, Coen PG, Jeanes A, Kozlakidis Z, Larkin L, Wurie F, Robotham JV, Jit M, Deeny SR.

Clin Infect Dis. 2018 Aug 16;67(5):693-700. doi: 10.1093/cid/ciy167.

21.

The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries.

Howard N, Bell S, Walls H, Blanchard L, Brenzel L, Jit M, Mounier-Jack S.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1539-1541. doi: 10.1080/21645515.2018.1444321. Epub 2018 Mar 26.

22.

Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9-14-year-old girls against human papillomavirus.

Jit M, Brisson M.

Int J Cancer. 2018 Jul 15;143(2):317-323. doi: 10.1002/ijc.31321. Epub 2018 Mar 1.

23.

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries.

Chang AY, Riumallo-Herl C, Perales NA, Clark S, Clark A, Constenla D, Garske T, Jackson ML, Jean K, Jit M, Jones EO, Li X, Suraratdecha C, Bullock O, Johnson H, Brenzel L, Verguet S.

Health Aff (Millwood). 2018 Feb;37(2):316-324. doi: 10.1377/hlthaff.2017.0861.

24.

Mini-review: Can non-human leucocyte antigen genes determine susceptibility to severe dengue syndromes?

Ng D, Ghosh A, Jit M, Seneviratne SL.

Trans R Soc Trop Med Hyg. 2017 Sep 1;111(9):384-392. doi: 10.1093/trstmh/trx075. Review.

PMID:
29351663
25.

Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.

Teresa Aguado M, Barratt J, Beard JR, Blomberg BB, Chen WH, Hickling J, Hyde TB, Jit M, Jones R, Poland GA, Friede M, Ortiz JR.

Vaccine. 2018 Feb 8;36(7):921-931. doi: 10.1016/j.vaccine.2017.12.029. Epub 2018 Jan 12.

26.

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.

Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, De Vlas SJ, Guzzetta G, Hontelez JAC, Horn J, Jepsen MR, Kim JJ, Lazzarato F, Matthijsse SM, Mikolajczyk R, Pavelyev A, Pillsbury M, Shafer LA, Tully SP, Turner HC, Usher C, Walsh C.

Lancet Public Health. 2016 Nov;1(1):e8-e17. doi: 10.1016/S2468-2667(16)30001-9. Epub 2016 Sep 27. Review.

27.

Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia.

Loganathan T, Ng CW, Lee WS, Hutubessy RCW, Verguet S, Jit M.

Health Policy Plan. 2018 Mar 1;33(2):204-214. doi: 10.1093/heapol/czx166.

PMID:
29228339
28.

Impact of measles supplementary immunization activities on reaching children missed by routine programs.

Portnoy A, Jit M, Helleringer S, Verguet S.

Vaccine. 2018 Jan 2;36(1):170-178. doi: 10.1016/j.vaccine.2017.10.080. Epub 2017 Nov 23.

29.

Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance.

Atkins KE, Lafferty EI, Deeny SR, Davies NG, Robotham JV, Jit M.

Lancet Infect Dis. 2018 Jun;18(6):e204-e213. doi: 10.1016/S1473-3099(17)30478-4. Epub 2017 Nov 13. Review.

PMID:
29146178
30.

Estimating burden of influenza-associated influenza-like illness and severe acute respiratory infection at public healthcare facilities in Romania during the 2011/12-2015/16 influenza seasons.

Gefenaite G, Pistol A, Popescu R, Popovici O, Ciurea D, Dolk C, Jit M, Gross D.

Influenza Other Respir Viruses. 2018 Jan;12(1):183-192. doi: 10.1111/irv.12525. Epub 2017 Dec 15.

31.

Estimating the opportunity costs of bed-days.

Sandmann FG, Robotham JV, Deeny SR, Edmunds WJ, Jit M.

Health Econ. 2018 Mar;27(3):592-605. doi: 10.1002/hec.3613. Epub 2017 Nov 6.

32.

Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England.

Mendes D, Mesher D, Pista A, Baguelin M, Jit M.

Eur J Public Health. 2018 Apr 1;28(2):343-347. doi: 10.1093/eurpub/ckx176.

33.

The impact of influenza on the health related quality of life in China: an EQ-5D survey.

Yang J, Jit M, Zheng Y, Feng L, Liu X, Wu JT, Yu H.

BMC Infect Dis. 2017 Oct 16;17(1):686. doi: 10.1186/s12879-017-2801-2.

34.

Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China.

Zheng Y, Jit M, Wu JT, Yang J, Leung K, Liao Q, Yu H.

PLoS One. 2017 Sep 21;12(9):e0184266. doi: 10.1371/journal.pone.0184266. eCollection 2017.

35.

Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness.

Lemieux-Mellouki P, Drolet M, Jit M, Gingras G, Brisson M.

Epidemics. 2017 Dec;21:80-87. doi: 10.1016/j.epidem.2017.08.001. Epub 2017 Aug 25.

36.
37.

Projecting social contact matrices in 152 countries using contact surveys and demographic data.

Prem K, Cook AR, Jit M.

PLoS Comput Biol. 2017 Sep 12;13(9):e1005697. doi: 10.1371/journal.pcbi.1005697. eCollection 2017 Sep.

38.

Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England.

Cromer D, van Hoek AJ, Newall AT, Pollard AJ, Jit M.

Lancet Public Health. 2017 Jul 31;2(8):e367-e374. doi: 10.1016/S2468-2667(17)30103-2. eCollection 2017 Aug.

39.

Social contact patterns relevant to the spread of respiratory infectious diseases in Hong Kong.

Leung K, Jit M, Lau EHY, Wu JT.

Sci Rep. 2017 Aug 11;7(1):7974. doi: 10.1038/s41598-017-08241-1.

40.

Characterizing measles transmission in India: a dynamic modeling study using verbal autopsy data.

Verguet S, Jones EO, Johri M, Morris SK, Suraweera W, Gauvreau CL, Jha P, Jit M.

BMC Med. 2017 Aug 10;15(1):151. doi: 10.1186/s12916-017-0908-3.

41.

Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis.

Bissett SL, Godi A, Jit M, Beddows S.

Vaccine. 2017 Jul 13;35(32):3922-3929. doi: 10.1016/j.vaccine.2017.06.028. Epub 2017 Jun 17. Review.

42.

Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11-2015/16.

Sandmann FG, Jit M, Robotham JV, Deeny SR.

J Hosp Infect. 2017 Sep;97(1):79-85. doi: 10.1016/j.jhin.2017.05.015. Epub 2017 May 25.

43.

Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study.

Van Minh H, My NTT, Jit M.

BMC Health Serv Res. 2017 May 15;17(1):353. doi: 10.1186/s12913-017-2297-x.

44.

Mortality in Pediatric Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.

Wong JJ, Jit M, Sultana R, Mok YH, Yeo JG, Koh JWJC, Loh TF, Lee JH.

J Intensive Care Med. 2017 Jan 1:885066617705109. doi: 10.1177/0885066617705109. [Epub ahead of print]

PMID:
28460591
45.

Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.

Sundaram N, Chen C, Yoong J, Luvsan ME, Fox K, Sarankhuu A, La Vincente S, Jit M.

Vaccine. 2017 Feb 15;35(7):1055-1063. doi: 10.1016/j.vaccine.2016.12.070. Epub 2017 Jan 18.

46.

Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men.

Lin A, Ong KJ, Hobbelen P, King E, Mesher D, Edmunds WJ, Sonnenberg P, Gilson R, Bains I, Choi YH, Tanton C, Soldan K, Jit M.

Clin Infect Dis. 2017 Mar 1;64(5):580-588. doi: 10.1093/cid/ciw845.

47.

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.

Flasche S, Jit M, Rodríguez-Barraquer I, Coudeville L, Recker M, Koelle K, Milne G, Hladish TJ, Perkins TA, Cummings DA, Dorigatti I, Laydon DJ, España G, Kelso J, Longini I, Lourenco J, Pearson CA, Reiner RC, Mier-Y-Terán-Romero L, Vannice K, Ferguson N.

PLoS Med. 2016 Nov 29;13(11):e1002181. doi: 10.1371/journal.pmed.1002181. eCollection 2016 Nov.

48.

Adding interventions to mass measles vaccinations in India.

Johri M, Verguet S, Morris SK, Sharma JK, Ram U, Gauvreau C, Jones E, Jha P, Jit M.

Bull World Health Organ. 2016 Oct 1;94(10):718-727. Epub 2016 Jul 5.

49.

Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system.

Loganathan T, Jit M, Hutubessy R, Ng CW, Lee WS, Verguet S.

Trop Med Int Health. 2016 Nov;21(11):1458-1467. doi: 10.1111/tmi.12766. Epub 2016 Aug 24.

50.

The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.

van Kleef E, Deeny SR, Jit M, Cookson B, Goldenberg SD, Edmunds WJ, Robotham JV.

Vaccine. 2016 Nov 4;34(46):5562-5570. doi: 10.1016/j.vaccine.2016.09.046. Epub 2016 Oct 7.

Supplemental Content

Support Center